Target intelligence / Profile preview

Ribosomal protein L31 pseudogene 33 (RPL31P33)

Target
RPL31P33
Molecular classification
Other (Pseudogene)[13][14]
01

Overview

Ribosomal protein L31 pseudogene 33 (RPL31P33) is classified as a processed pseudogene in the human genome and does not encode a functional protein[13][14][11]. Pseudogenes are gene sequences derived from functional genes but have lost the ability to code for a protein, often due to mutations or lack of regulatory elements. RPL31P33 is related by sequence to the ribosomal protein L31, which is a structural component of the large ribosomal subunit, but RPL31P33 itself is not functional and does not produce a ribosomal protein. As with most ribosomal protein pseudogenes, there are currently no established biological functions, clinical associations, or therapeutic applications for RPL31P33 in humans[13][14][11]. This entry is not considered a therapeutic target in any functional context.

Other names
RPL31_13_704RPL31P33[13][14]
02

Mechanism of action

None (no known functional or druggable mechanism due to absence of protein product)

03

Biological functions

None (no protein product; does not participate directly in canonical biological functions)[13][14]
04

Disease associations

Other (No direct disease association; pseudogenes may have occasional roles in gene regulation, but none are documented for this locus.)[13][14]

Beyond the preview

Go deeper on Ribosomal protein L31 pseudogene 33 (RPL31P33).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L31 pseudogene 33 (RPL31P33).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call